Search results
Drew Weissman (born September 7, 1959) is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
Drew Weissman is a professor and director of vaccine research at the University of Pennsylvania. He discovered a novel nucleoside-modified mRNA platform that led to the first COVID-19 vaccines and other therapeutics.
May 13, 2024 · Drew Weissman is an American immunologist whose groundbreaking research into RNA (ribonucleic acid) opened the path to the development of RNA therapeutics, most notably the generation of messenger RNA (mRNA) vaccines.
Dr. Weissman is a Nobel laureate for his contributions to mRNA vaccine technology against COVID-19. He is also a leading expert in RNA biology, HIV immunology, and gene therapy at Penn Medicine.
Dr. Weissman is a renowned physician and researcher who invented the modified mRNA technology for COVID-19 vaccines. He and his team are also working on other mRNA vaccines and therapeutics for coronaviruses, flu, herpes, and cancer.
Oct 2, 2023 · Drew Weissman, the Roberts Family Professor of Vaccine Research at Penn, is one of the recipients of the 2023 Nobel Prize in Medicine for his work on mRNA technology. He and his partner Katalin Karikó developed the platform that enabled the rapid development of COVID-19 vaccines by Pfizer/BioNTech and Moderna.
Dr. Weissman's laboratory focuses on the study of RNA and innate immune system biology and the application of these findings to vaccine research and gene therapy. There are three main projects in his laboratory.
